As of 2024-07-27, the Relative Valuation of PTC Therapeutics Inc (PTCT) is (233.94) USD. This relative valuation is based on P/E multiples. With the latest stock price at 34.09 USD, the upside of PTC Therapeutics Inc based on Relative Valuation is -786.2%.
The range of the Relative Valuation is (232.31) - (238.35) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 30.8x - 35.0x | 31.3x |
| Forward P/E multiples | 29.0x - 31.6x | 30.6x |
| Fair Price | (232.31) - (238.35) | (233.94) |
| Upside | -781.5% - -799.2% | -786.2% |
| Date | P/E |
| 2024-07-26 | -4.51 |
| 2024-07-25 | -4.44 |
| 2024-07-24 | -4.50 |
| 2024-07-23 | -4.44 |
| 2024-07-22 | -4.37 |
| 2024-07-19 | -4.32 |
| 2024-07-18 | -4.34 |
| 2024-07-17 | -4.53 |
| 2024-07-16 | -4.52 |
| 2024-07-15 | -4.39 |
| 2024-07-12 | -4.41 |
| 2024-07-11 | -4.40 |
| 2024-07-10 | -4.21 |
| 2024-07-09 | -4.18 |
| 2024-07-08 | -4.20 |
| 2024-07-05 | -4.10 |
| 2024-07-03 | -4.10 |
| 2024-07-02 | -4.02 |
| 2024-07-01 | -4.13 |
| 2024-06-28 | -4.05 |
| 2024-06-27 | -4.59 |
| 2024-06-26 | -4.64 |
| 2024-06-25 | -4.65 |
| 2024-06-24 | -4.74 |
| 2024-06-21 | -4.84 |
| 2024-06-20 | -4.41 |
| 2024-06-18 | -4.72 |
| 2024-06-17 | -4.69 |
| 2024-06-14 | -4.74 |
| 2024-06-13 | -4.89 |
| 2024-06-12 | -4.99 |
| 2024-06-11 | -4.99 |
| 2024-06-10 | -4.98 |
| 2024-06-07 | -4.84 |
| 2024-06-06 | -4.89 |
| 2024-06-05 | -5.03 |
| 2024-06-04 | -5.02 |
| 2024-06-03 | -4.96 |
| 2024-05-31 | -4.81 |
| 2024-05-30 | -4.74 |
| 2024-05-29 | -4.64 |
| 2024-05-28 | -4.83 |
| 2024-05-24 | -4.93 |
| 2024-05-23 | -4.92 |
| 2024-05-22 | -5.12 |
| 2024-05-21 | -5.14 |
| 2024-05-20 | -5.31 |
| 2024-05-17 | -4.38 |
| 2024-05-16 | -4.51 |
| 2024-05-15 | -4.46 |